quinoxalines has been researched along with oxytocin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argiolas, A; Melis, MR; Stancampiano, R | 1 |
| Crowley, WR; Parker, SL | 2 |
| Cui, LN; Dyball, RE; Saeb-Parsy, K | 1 |
| Richardson, CM; Wakerley, JB | 1 |
| Armstrong, WE; Foehring, RC; Galarreta, M; Hestrin, S; Stern, JE | 1 |
| Buijs, RM; Hermes, ML; Klop, A; Renaud, LP; Ruijter, JM | 1 |
| Díaz-Cabiale, Z; Fuxe, K; Narváez, JA; Petersson, M; Uvnäs-Moberg, K | 2 |
| Ingram, JN; Renfree, MB; Shaw, G | 1 |
| Buxton, IL; Kaiser, RA; Malmquist, NA; Tichenor, S | 1 |
| Kolaj, M; Oz, M; Renaud, LP | 1 |
| Emch, GS; Hermann, GE; Rogers, RC | 1 |
| Garfield, RE; Jain, V; Longo, M; Saade, GR; Vedernikov, YP | 1 |
| Goraca, A | 1 |
| Angel Narváez, J; Diaz-Cabiale, Z; Fuxe, K; Petersson, M; Uvnäs-Moberg, K | 1 |
| Magara, F; Stoop, R; Terrettaz, T; Viviani, D | 1 |
| Antunes-Rodrigues, J; Cunha, FQ; Elias, LL; Giusti-Paiva, A; Gomes, DA; Ventura, RR | 1 |
| Aguila, FA; Basso, PJ; Oliveira-Pelegrin, GR; Rocha, MJ | 1 |
| Cetin, AH; Charlet, A; Eliava, M; Grinevich, V; Hoffmann, LC; Khrulev, S; Knobloch, HS; Osten, P; Schwarz, MK; Seeburg, PH; Stoop, R | 1 |
| Antunes-Rodrigues, J; Busnardo, C; Corrêa, FM; Crestani, CC; Resstel, LB; Tavares, RF | 1 |
| Althammer, F; Busnelli, M; Chao, MV; Charlet, A; Chavant, V; Chini, B; Ciobanu, AC; da Silva Gouveia, M; Eliava, M; Froemke, RC; Giese, G; Goumon, Y; Grinevich, V; Gruber, T; Knobloch-Bollmann, HS; Kuner, R; Melchior, M; Mitre, M; Petit-Demoulière, N; Poisbeau, P; Roth, LC; Seeburg, PH; Sprengel, R; Stoop, R; Tan, LL; Tang, Y; Triana Del Rio, R; Wahis, J | 1 |
22 other study(ies) available for quinoxalines and oxytocin
| Article | Year |
|---|---|
Effect of excitatory amino acid receptor antagonists on apomorphine-, oxytocin- and ACTH-induced penile erection and yawning in male rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenocorticotropic Hormone; Aminobutyrates; Animals; Apomorphine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Oxytocin; Penile Erection; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Amino Acid; Yawning | 1992 |
Stimulation of oxytocin release in the lactating rat by central excitatory amino acid mechanisms: evidence for specific involvement of R,S-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-sensitive glutamate receptors.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids; Animals; Brain; Calcium Channel Blockers; Female; Lactation; Oxytocin; Prolactin; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Glutamate; Sodium Channel Blockers; Vasopressins | 1993 |
Stimulation of oxytocin release in the lactating rat by a central interaction of alpha 1-adrenergic and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-sensitive excitatory amino acid mechanisms.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids; Animals; Brain; Drug Synergism; Female; Lactation; Oxytocin; Phenylephrine; Quinoxalines; Rats; Receptors, Adrenergic, alpha; Supraoptic Nucleus | 1993 |
Neurones in the supraoptic nucleus of the rat are regulated by a projection from the suprachiasmatic nucleus.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Bicuculline; Evoked Potentials; Excitatory Amino Acid Antagonists; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Neural Pathways; Neurons; Optic Nerve; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Wistar; Receptors, GABA-A; Suprachiasmatic Nucleus; Supraoptic Nucleus; Vasopressins | 1997 |
Glutamate excitation of oxytocin neurones in vitro involves predominantly non-NMDA receptors.
Topics: 2-Amino-5-phosphonovalerate; Animals; Enkephalin, Leucine-2-Alanine; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; In Vitro Techniques; Neurons; Oxytocin; Quinoxalines; Rats; Rats, Wistar | 1997 |
Differences in the properties of ionotropic glutamate synaptic currents in oxytocin and vasopressin neuroendocrine neurons.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Evoked Potentials; Excitatory Amino Acid Antagonists; Female; Hypothalamus; In Vitro Techniques; Neurons; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Supraoptic Nucleus; Synapses; Vasopressins | 1999 |
Vasopressin increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons in vitro.
Topics: Action Potentials; Animals; Bicuculline; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Interneurons; Male; Neural Inhibition; Oxytocin; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Long-Evans; Receptors, GABA-A; Synaptic Transmission; Tetrodotoxin; Vasoconstrictor Agents; Vasopressins | 2000 |
Oxytocin/alpha(2)-Adrenoceptor interactions in feeding responses.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Autoradiography; Brain; Brimonidine Tartrate; Clonidine; Eating; Injections, Intraventricular; Male; Oxytocin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Tissue Distribution | 2000 |
Systemic oxytocin treatment modulates alpha 2-adrenoceptors in telencephalic and diencephalic regions of the rat.
Topics: Adrenergic alpha-Agonists; Amygdala; Animals; Autoradiography; Brimonidine Tartrate; Diencephalon; Hypothalamus; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Telencephalon; Tritium | 2000 |
Differential regulation of contractility and nitric oxide sensitivity in gravid and nongravid myometrium during late pregnancy in a marsupial.
Topics: Animals; Cyclic GMP; Enzyme Inhibitors; Female; Gestational Age; Guanylate Cyclase; Kinetics; Marsupialia; Myometrium; Nitric Oxide; Oxadiazoles; Oxytocin; Pregnancy; Quinoxalines; Uterine Contraction | 2001 |
NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.
Topics: Charybdotoxin; Cyclic GMP; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; In Vitro Techniques; Labor, Obstetric; Molsidomine; Muscle Relaxation; Muscle, Smooth; Myometrium; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Oxytocin; Penicillamine; Peptides; Pregnancy; Quinoxalines; S-Nitrosothiols; Scorpion Venoms; Time Factors; Uterus | 2001 |
Electrophysiological evidence for vasopressin V(1) receptors on neonatal motoneurons, premotor and other ventral horn neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Anterior Horn Cells; Arginine Vasopressin; Bicuculline; Deamino Arginine Vasopressin; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; Glycine Agents; Hemosiderin; Hormone Antagonists; Interneurons; Male; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Strychnine; Vasotocin | 2001 |
TNF-alpha-induced c-Fos generation in the nucleus of the solitary tract is blocked by NBQX and MK-801.
Topics: Animals; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Microinjections; Neurons; Oxytocin; Proto-Oncogene Proteins c-fos; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Solitary Nucleus; Tumor Necrosis Factor-alpha | 2001 |
Effects of recombinant human relaxin on pregnant rat uterine artery and myometrium in vitro.
Topics: Adenine; Animals; Arteries; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Myometrium; NG-Nitroarginine Methyl Ester; Oxadiazoles; Oxytocin; Pregnancy; Protein Kinase C; Quinoxalines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Relaxin; Uterine Contraction | 2003 |
Oxytocin content in the venous blood outflowing from the vicinity of the cavernous sinus and from the femoral vein.
Topics: Animals; Cavernous Sinus; Femoral Vein; Hypoxia; Male; N-Methylaspartate; Oxytocin; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2004 |
Oxytocin increases the density of high affinity alpha(2)-adrenoceptors within the hypothalamus, the amygdala and the nucleus of the solitary tract in ovariectomized rats.
Topics: Adrenergic alpha-Agonists; Amygdala; Animals; Autoradiography; Binding Sites; Brimonidine Tartrate; Dose-Response Relationship, Drug; Female; Hypothalamus; Ovariectomy; Oxytocin; Quinoxalines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Solitary Nucleus; Tritium | 2005 |
Oxytocin enhances the inhibitory effects of diazepam in the rat central medial amygdala.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Diazepam; Drug Synergism; Electric Stimulation; Excitatory Amino Acid Antagonists; Female; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Neural Inhibition; Neurons; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley | 2010 |
Carbon monoxide and nitric oxide modulate hyperosmolality-induced oxytocin secretion by the hypothalamus in vitro.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Carbon Monoxide; Enzyme Inhibitors; Hypothalamus; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Nitroprusside; Osmotic Pressure; Oxadiazoles; Oxytocin; Quinoxalines; Rats; Rats, Wistar | 2010 |
Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis.
Topics: Animals; Arginine Vasopressin; Cyclic GMP; Enzyme Inhibitors; Gene Expression Regulation; Male; Nitric Oxide; Oxadiazoles; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Sepsis; Signal Transduction; Supraoptic Nucleus | 2010 |
Evoked axonal oxytocin release in the central amygdala attenuates fear response.
Topics: Action Potentials; Amygdala; Analysis of Variance; Animals; Axons; Behavior, Animal; Conditioning, Psychological; Excitatory Amino Acid Antagonists; Fear; Female; Fiber Optic Technology; GABA Antagonists; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Hypothalamus; In Vitro Techniques; Inhibition, Psychological; Lactation; Light; Microscopy, Electron, Transmission; Models, Biological; Neurons; Oxytocin; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Picrotoxin; Prosencephalon; Quinoxalines; Rats; Rats, Wistar; Rhodopsin; Time Factors; Vasotocin; Vesicular Glutamate Transport Protein 2 | 2012 |
Ionotropic glutamate receptors in hypothalamic paraventricular and supraoptic nuclei mediate vasopressin and oxytocin release in unanesthetized rats.
Topics: Animals; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Microinjections; N-Methylaspartate; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Supraoptic Nucleus; Vasopressins | 2012 |
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing.
Topics: Action Potentials; Animals; Cholecystokinin; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Inflammation; Neural Pathways; Neuralgia; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Receptors, Oxytocin; Spinal Cord; Supraoptic Nucleus; Transduction, Genetic; Vasopressins; Vesicular Glutamate Transport Protein 2 | 2016 |